Center for Drug Evaluation and Research (U.S.) & Center for Biologics Evaluation and Research (U.S.). (1995). Guidance for industry: Content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products. Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research.
Chicago Style (17th ed.) CitationCenter for Drug Evaluation and Research (U.S.) and Center for Biologics Evaluation and Research (U.S.). Guidance for Industry: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-characterized, Therapeutic, Biotechnology-derived Products. [Rockville, Md.]: Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 1995.
MLA (9th ed.) CitationCenter for Drug Evaluation and Research (U.S.) and Center for Biologics Evaluation and Research (U.S.). Guidance for Industry: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-characterized, Therapeutic, Biotechnology-derived Products. Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 1995.